|
|
||||||||
1From the Departments of Ophthalmology and Visual Sciences, 3Pathology, and 4Biomedical Engineering, and the 2Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee.
PURPOSE. There are two human 15-lipoxygenases (LOX), 15-LOX-1 and -2, which convert arachidonic acid to 15S-hydroxyeicosatetraenoic acid (15S-HETE). The presence of both 15-LOXs in the human cornea prompted this study to delineate their roles in the human corneal epithelium.
METHODS. Human corneal epithelia from donor corneas and a human corneal epithelial (HCE) cell line were used in [1-14C]arachidonic acid incubations, Western blot analysis, and quantitative real-time RT-PCR. Cell cultures of HCE were treated with 15S-HETE to measure its effect on cell growth. HCE cells were transfected with plasmids to express green fluorescent (GFP) fusion proteins of 15-LOX-1 and -2, and in vivo laser confocal microscopy was performed to determine the subcellular localization of the 15-LOX fusion proteins.
RESULTS. [1-14C]Arachidonic acid incubations yielded 15S-HETE as the only LOX product. Treatment with 15S-HETE (510 µM) reduced growth rate and induced apoptosis in cultured HCE cells in a dose-dependent manner. 15-LOX-2 but not 15-LOX-1 was detected by Western blot analysis, although we were able to detect similar levels of both 15-LOX mRNAs by real-time quantitative RT-PCR. 15-LOX-1 and -2 proteins showed different subcellular expression patterns. 15-LOX-2 GFP was expressed in the cytoplasm and nucleus (actively taken up into the nucleus). 15-LOX-1 GFP fusion protein expression was restricted to the cytoplasm.
CONCLUSIONS. These findings indicate that 15-LOX-2 is the predominant 15-LOX protein in human cornea, and its product, 15S-HETE, plays a role in cellular proliferation. Because the two 15-LOXs have different subcellular compartmentalization, the authors hypothesize that their products are also compartmentalized and therefore exert different molecular effects in the human corneal epithelium.
This article has been cited by other articles:
![]() |
K. Gronert Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege Mol. Interv., February 1, 2008; 8(1): 28 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bajpai, E. Blaskova, S. B. Pakala, T. Zhao, W. C. Glasgow, J. S. Penn, D. A. Johnson, and G. N. Rao 15(S)-HETE Production in Human Retinal Microvascular Endothelial Cells by Hypoxia: Novel Role for MEK1 in 15(S)-HETE Induced Angiogenesis Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4930 - 4938. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biteman, I. R. Hassan, E. Walker, A. J. Leedom, M. Dunn, F. Seta, M. Laniado-Schwartzman, and K. Gronert Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing FASEB J, July 1, 2007; 21(9): 2257 - 2266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schweiger, G. Furstenberger, and P. Krieg Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signaling pathways J. Lipid Res., March 1, 2007; 48(3): 553 - 564. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |